Supplement Marketer Welcomes Friendlier Regime Under RFK Jr. 12 19 2024 Peptide Therapy 101: Can BPC 157 & Thymosin Beta 4 Accelerate Ortho Recovery? The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System